Abstract:Introduction: Major neurocognitive disorder (or simply Dementia) is one of the main causes of disability and burden disease to caregivers and the health system, and a frequent cause of mortality worldwide. Alzheimer`s disease (AD) is the most common type (60-70%). AD is a progressive neurodegenerative disorder characterized by amyloid-β (Aβ) deposition, causing neuronal and synaptic loss with subsequent cognitive disfunction. There is cumulating evidence that sleep disturbances are associated with several pathological conditions, and AD is one of these. The prevalence and severity of sleep disorders is significant in AD patients, with sleep disturbances often precede its clinical diagnosis in many years. Some studies focus on possible mechanisms by which (abnormal) sleep participate in AD pathogenesis, and concluded individuals with sleep disturbances are at higher risk of developing dementia. Objectives: To highlight the current evidence on whether sleep disorders could precipitate or accelerate the clinical course of AD. Methods: Non-systematic review about sleep abnormalities and AD pathogenesis. Results: Several authors described a two-way relationship between sleep and amyloid pathology - sleep deprivation would lead to increased production and decreased clearance of Aβ; once Aβ is accumulated it results in more disrupted sleep, with an increase of Aβ production during wakefulness and a decrease of its clearance during sleep. Recent data showed that sleep continuity and architecture (decreased total sleep time, slow-wave sleep, and REM sleep) are disturbed in AD patients. Otherwise, sleep deprivation may be associated with decreased glymphatic system clearance, leading to accumulation of neurotoxic proteins, particularly Aβ (and tau). It`s also associated with proinflammatory states due to accumulation of reactive oxygen species, nucleotides and proteins during wakefulness, which leads to immune response that causes neuronal dysfunction and cellular death. Insomnia and sleep deprivation were also associated with activation of complement pathway and immunoglobulins secretion. Many studies suggest chronic sleep disruption changes blood–brain barrier structure and function leading to Aβ accumulation. Conclusions: There is emerging evidence that points sleep disturbances as both a potential marker for AD pathology and risk predictor of developing the disease. Future investigations should evaluate the relationship between specific sleep disorders and AD physiopathology.

Sleep and diurnal alternative polyadenylation sites associated with human APA-linked brain disorders

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden

Circadian Rhythm Sleep Disorders and Time-of-day-dependent Memory Deficiency in Presenilin1/2 Conditional Knockout Mice with Long Noncoding RNA Expression Profiling Changes.

Sleep and Alzheimer’s Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects

Insights into Behavioral Vulnerability to Differential Sleep Pressure and Circadian Phase from a Functional ADA Polymorphism

From Single Nucleotide Variations to Genes: Identifying the Genetic Links Between Sleep and Psychiatric Disorders

From SNVs to Genes: Identifying the Genetic Links Between Sleep and Psychiatric Disorders

Isoform-specific regulation of rhythmic gene expression by alternative polyadenylation

Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice

Sleep and Late-Onset Alzheimer's Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects

Deficiency of Autism-Related Scn2a Gene in Mice Disrupts Sleep Patterns and Circadian Rhythms

Dynamic Landscape of Alternative Polyadenylation During Retinal Development

Impaired clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in a mouse model of Alzheimer’s disease

Chronic sleep deprivation altered the expression of circadian clock genes and aggravated Alzheimer's disease neuropathology

P155: Circadian Rhythms and Alzheimer's Disease

Influence of Sleep Disruption on Protein Accumulation in Neurodegenerative Diseases

Spatial transcriptomics identifies disrupted circadian gene expression in a mouse model of Alzheimer’s disease

Sleep Loss Drives Brain Region-Specific and Cell Type-Specific Alterations in Ribosome-Associated Transcripts Involved in Synaptic Plasticity and Cellular Timekeeping

Parkinson’s Disease is Associated with Dysregulations of a Dopamine-Modulated Gene Network Relevant to Sleep and Affective Neurobehaviors in the Striatum

Altered hippocampal transcriptome dynamics following sleep deprivation

Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease